SCHEMBL29975438

SCHEMBL29975438

NC(=O)c1cccc(Cl)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.49
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 4/20 0.47
LMNA P02545 1/20 0.47
KAT6A Q92794 1/20 0.46
KMT2A Q03164 2/20 0.46
ATM Q13315 1/20 0.46
TSHR P16473 2/20 0.45
CES2 O00748 2/20 0.45
CES1 P23141 2/20 0.45
CD38 P28907 2/20 0.44
HPGD P15428 2/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2175638 1.00 PBRM1 (0.49) PBRM1KDM4EALDH1A1LMNAKAT6A
SCHEMBL27214503 0.84 ALDH1A1 (0.52) KDM4EALDH1A1KMT2ATSHRCES2
SCHEMBL27919384 0.83 PARP1 (0.50) PBRM1KDM4EALDH1A1LMNAKMT2A
SCHEMBL27710545 0.83 KEAP1 (0.49) PBRM1KDM4EALDH1A1LMNAKMT2A
SCHEMBL29454770 0.81 ALDH1A1 (0.54) ALDH1A1KAT6AKMT2ATSHRCES2
SCHEMBL401838 0.81 TSHR (0.63) PBRM1KDM4EALDH1A1LMNAKAT6A
SCHEMBL30462062 0.81 TSHR (0.63) PBRM1KDM4EALDH1A1LMNAKAT6A
SCHEMBL9693738 0.81 KAT6A (0.47) ALDH1A1KAT6AKMT2ATSHRCES2
SCHEMBL413285 0.81 ALDH1A1 (0.54) ALDH1A1KAT6AKMT2ATSHRCES2
Hydrochloric Acid SCHEMBL10557491 0.79 TSHR (0.61) PBRM1KDM4EALDH1A1LMNAKAT6A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4329757-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-03-06 EP disclosed
WO-2022232331-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-11-03 WO disclosed